Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vistakon Pharmaceuticals
Age
21–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
willing to comply with investigator's and protocol's instructions
patients signature on the informed consent document
primary open-angle glaucoma, pigment dispersion or exfoliation glaucoma, or ocular hypertension in at least one eye
at screening intraocular pressure must be considered to be safe, in both eyes
in non-qualifying eyes the intraocular pressure should be able to be controlled safely on no pharmacologic therapy or on study medicine alone
currently treated with one glaucoma medication, untreated intraocular pressure of less than or equal to 28 mm Hg at visit 2 in both eyes
You may not be if
any abnormality preventing reliable applanation tonometry in either eye
any opacity or subject uncooperativeness that restricts adequate examination of the ocular fundus or anterior chamber in either eye
any concurrent infectious/noninfectious conjunctivitis, keratitis or uveitis in either eye
any history of allergic hypersensitivity or poor tolerance to any components of the preparations used in this trial
females of childbearing potential not using reliable means of birth control
pregnant or lactating females
any clinically significant, serious, or severe medical or psychiatric condition
participation (or current participation) in any investigational drug or device trial within 30 days prior to Visit 1
severe prior visual acuity or field loss from any cause
inability to understand the trial procedures, and thus inability to give informed consent
progressive retinal or optic nerve disease apart from glaucoma
serious systemic or ocular disease
intraocular laser surgery within the past three months or corneal or intraocular conventional surgery within the past 6 months
concurrent use of systemic corticosteroids, by IV, oral, dermal or topical ophthalmic route.
subjects requiring tear replacement drops or allergy medications with sympathomimetics 24 hours prior to a scheduled study visit
contraindication to beta-blocker usage including: reactive airway disease, uncontrolled heart failure, or second as well as third degree cardiac block, myasthenia gravis
any subject the investigator believes will be at risk for glaucomatous progression by their participation in this trial
Clareo Health | Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
